241 related articles for article (PubMed ID: 28542441)
1. DOT or SAT for Rifampicin-resistant tuberculosis? A non-randomized comparison in a high HIV-prevalence setting.
Mohr E; Daniels J; Beko B; Isaakidis P; Cox V; Steele SJ; Muller O; Snyman L; De Azevedo V; Shroufi A; Trivino Duran L; Hughes J
PLoS One; 2017; 12(5):e0178054. PubMed ID: 28542441
[TBL] [Abstract][Full Text] [Related]
2. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries.
Pettit AC; Jenkins CA; Blevins Peratikos M; Yotebieng M; Diero L; Do CD; Ross J; Veloso VG; Hawerlander D; Marcy O; Shepherd BE; Fenner L; Sterling TR;
J Int AIDS Soc; 2019 Dec; 22(12):e25423. PubMed ID: 31814312
[TBL] [Abstract][Full Text] [Related]
3. Home-Based and Facility-Based Directly Observed Therapy of Tuberculosis Treatment under Programmatic Conditions in Urban Tanzania.
Mhimbira F; Hella J; Maroa T; Kisandu S; Chiryamkubi M; Said K; Mhalu G; Mkopi A; Mutayoba B; Reither K; Gagneux S; Fenner L
PLoS One; 2016; 11(8):e0161171. PubMed ID: 27513331
[TBL] [Abstract][Full Text] [Related]
4. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
5. Twice-weekly, directly observed treatment for HIV-infected and uninfected tuberculosis patients: cohort study in rural South Africa.
Davies GR; Connolly C; Sturm AW; McAdam KP; Wilkinson D
AIDS; 1999 May; 13(7):811-7. PubMed ID: 10357380
[TBL] [Abstract][Full Text] [Related]
6. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
Nglazi MD; Bekker LG; Wood R; Kaplan R
BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
[TBL] [Abstract][Full Text] [Related]
7. Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success.
Daniels JF; Khogali M; Mohr E; Cox V; Moyo S; Edginton M; Hinderaker SG; Meintjes G; Hughes J; De Azevedo V; van Cutsem G; Cox HS
PLoS One; 2015; 10(11):e0142873. PubMed ID: 26555134
[TBL] [Abstract][Full Text] [Related]
8. Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea.
Hassane-Harouna S; Gils T; Decroo T; Ortuño-Gutiérrez N; Delamou A; Cherif GF; Camara LM; Rigouts L; de Jong BC
Glob Health Action; 2023 Dec; 16(1):2262134. PubMed ID: 37799061
[TBL] [Abstract][Full Text] [Related]
9. Directly observed therapy (DOT) is not the entire answer: an operational cohort analysis.
Mangura B; Napolitano E; Passannante M; Sarrel M; McDonald R; Galanowsky K; Reichman L
Int J Tuberc Lung Dis; 2002 Aug; 6(8):654-61. PubMed ID: 12150475
[TBL] [Abstract][Full Text] [Related]
10. Directly observed therapy and improved tuberculosis treatment outcomes in Thailand.
Anuwatnonthakate A; Limsomboon P; Nateniyom S; Wattanaamornkiat W; Komsakorn S; Moolphate S; Chiengsorn N; Kaewsa-Ard S; Sombat P; Siangphoe U; Mock PA; Varma JK
PLoS One; 2008 Aug; 3(8):e3089. PubMed ID: 18769479
[TBL] [Abstract][Full Text] [Related]
11. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies.
Alipanah N; Jarlsberg L; Miller C; Linh NN; Falzon D; Jaramillo E; Nahid P
PLoS Med; 2018 Jul; 15(7):e1002595. PubMed ID: 29969463
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
Boulle A; Van Cutsem G; Cohen K; Hilderbrand K; Mathee S; Abrahams M; Goemaere E; Coetzee D; Maartens G
JAMA; 2008 Aug; 300(5):530-9. PubMed ID: 18677025
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register.
Schnippel K; Shearer K; Evans D; Berhanu R; Dlamini S; Ndjeka N
Int J Infect Dis; 2015 Oct; 39():89-94. PubMed ID: 26358856
[TBL] [Abstract][Full Text] [Related]
14. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.
Webb Mazinyo E; Kim L; Masuku S; Lancaster JL; Odendaal R; Uys M; Podewils LJ; Van der Walt ML
PLoS One; 2016; 11(7):e0159317. PubMed ID: 27442440
[TBL] [Abstract][Full Text] [Related]
15. "Life continues": Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.
Mohr E; Snyman L; Mbakaz Z; Caldwell J; DeAzevedo V; Kock Y; Trivino Duran L; Venables E
PLoS One; 2018; 13(9):e0203888. PubMed ID: 30216368
[TBL] [Abstract][Full Text] [Related]
16. Patient-centred tuberculosis treatment delivery under programmatic conditions in Tanzania: a cohort study.
Egwaga S; Mkopi A; Range N; Haag-Arbenz V; Baraka A; Grewal P; Cobelens F; Mshinda H; Lwilla F; van Leth F
BMC Med; 2009 Dec; 7():80. PubMed ID: 20025724
[TBL] [Abstract][Full Text] [Related]
17. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
18. Patients perceived stigma associated with community-based directly observed therapy of tuberculosis in Uganda.
Katamba A; Neuhauser DB; Smyth KA; Adatu F; Katabira E; Whalen CC
East Afr Med J; 2005 Jul; 82(7):337-42. PubMed ID: 16167705
[TBL] [Abstract][Full Text] [Related]
19. Acquired rifampicin resistance in thrice-weekly antituberculosis therapy: impact of HIV and antiretroviral therapy.
Narendran G; Menon PA; Venkatesan P; Vijay K; Padmapriyadarsini C; Ramesh Kumar S; Bhavani KP; Sekar L; Gomathi SN; Chandrasekhar C; Kumar S; Sridhar R; Swaminathan S
Clin Infect Dis; 2014 Dec; 59(12):1798-804. PubMed ID: 25156114
[TBL] [Abstract][Full Text] [Related]
20. Nine- to Twelve-Month Anti-Tuberculosis Treatment Is Associated with a Lower Recurrence Rate than 6-9-Month Treatment in Human Immunodeficiency Virus-Infected Patients: A Retrospective Population-Based Cohort Study in Taiwan.
Wang JY; Sun HY; Wang JT; Hung CC; Yu MC; Lee CH; Lee LN
PLoS One; 2015; 10(12):e0144136. PubMed ID: 26633835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
